Skip to ContentSkip to Navigation
About us Practical matters How to find us M.V. Hovingh

Publications

Bile Acid Sequestration via Colesevelam Reduces Bile Acid Hydrophobicity and Improves Liver Pathology in Cyp2c70-/- Mice with a Human-like Bile Acid Composition

Characterization of a novel bile salt export pump deficiency mouse model with the p.E297g mutation

Gut microbiota depletion aggravates bile acid-induced liver pathology in mice with a human-like bile acid composition

Perinatal exposure to UDCA prevents neonatal cholestasis in Cyp2c70-/- mice with human-like bile acids

Short-term obeticholic acid treatment does not impact cholangiopathy in Cyp2c70-deficient mice with a human-like bile acid composition

Cholangiopathy and biliary fibrosis in Cyp2c70-deficient mice are fully reversed by ursodeoxycholic acid

Low production of 12 alpha-hydroxylated bile acids prevents hepatic steatosis in Cyp2c70(-/-) mice by reducing fat absorption

Low production of 12 alpha-hydroxylated bile acids prevents hepatic steatosis in mice with a human-like bile acid pool by reducing fat absorption

URSODEOXYCHOLIC ACID TREATMENT OF MOTHERS DURING PREGNANCY AND SUCKLING PREVENTS NEONATAL CHOLESTASIS IN NEWBORN Cyp2c70-/- MICE WITH A HUMAN-LIKE BILE ACID POOL

A HUMAN-LIKE COMPOSITION OF THE CIRCULATING BILE ACID POOL IMPACTS ON PLASMA LDL CHOLESTEROL IN MICE

Read more